388 related articles for article (PubMed ID: 25648699)
1. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
[TBL] [Abstract][Full Text] [Related]
2. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
3. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
4. SOCS3 is an endogenous inhibitor of pathologic angiogenesis.
Stahl A; Joyal JS; Chen J; Sapieha P; Juan AM; Hatton CJ; Pei DT; Hurst CG; Seaward MR; Krah NM; Dennison RJ; Greene ER; Boscolo E; Panigrahy D; Smith LE
Blood; 2012 Oct; 120(14):2925-9. PubMed ID: 22791286
[TBL] [Abstract][Full Text] [Related]
5. SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth.
Sun Y; Ju M; Lin Z; Fredrick TW; Evans LP; Tian KT; Saba NJ; Morss PC; Pu WT; Chen J; Stahl A; Joyal JS; Smith LE
Sci Signal; 2015 Sep; 8(395):ra94. PubMed ID: 26396267
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
[TBL] [Abstract][Full Text] [Related]
7. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 and its role in associated diseases.
Yin Y; Liu W; Dai Y
Hum Immunol; 2015 Oct; 76(10):775-80. PubMed ID: 26429311
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3.
Lan F; Zhang N; Zhang J; Krysko O; Zhang Q; Xian J; Derycke L; Qi Y; Li K; Liu S; Lin P; Bachert C
J Allergy Clin Immunol; 2013 Dec; 132(6):1314-21. PubMed ID: 23910692
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells.
Akifusa S; Kamio N; Shimazaki Y; Yamaguchi N; Nonaka K; Yamashita Y
J Cell Biochem; 2010 Oct; 111(3):597-606. PubMed ID: 20564237
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.
Miyazaki T; Miyazaki A
J Atheroscler Thromb; 2018 Jan; 25(1):1-15. PubMed ID: 28819082
[TBL] [Abstract][Full Text] [Related]
12. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
14. Protective role of JAK/STAT signaling against renal fibrosis in mice with unilateral ureteral obstruction.
Koike K; Ueda S; Yamagishi S; Yasukawa H; Kaida Y; Yokoro M; Fukami K; Yoshimura A; Okuda S
Clin Immunol; 2014 Jan; 150(1):78-87. PubMed ID: 24333535
[TBL] [Abstract][Full Text] [Related]
15. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.
Sands WA; Woolson HD; Milne GR; Rutherford C; Palmer TM
Mol Cell Biol; 2006 Sep; 26(17):6333-46. PubMed ID: 16914720
[TBL] [Abstract][Full Text] [Related]
16. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.
Pirvulescu M; Manduteanu I; Gan AM; Stan D; Simion V; Butoi E; Calin M; Simionescu M
Biochem Biophys Res Commun; 2012 Jun; 422(2):321-6. PubMed ID: 22575502
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced decreases in SOCS3 increase STAT3 activation and upregulate VEGF gene expression.
Yokogami K; Yamashita S; Takeshima H
Brain Tumor Pathol; 2013 Jul; 30(3):135-43. PubMed ID: 23104276
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
19. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.
Zitman-Gal T; Einbinder Y; Ohana M; Katzav A; Kartawy A; Benchetrit S
J Diabetes; 2019 Aug; 11(8):656-664. PubMed ID: 30575282
[TBL] [Abstract][Full Text] [Related]
20. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
